Navigation Links
CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
Date:3/29/2009

ORLANDO, Fla., March 29 /PRNewswire-FirstCall/ -- Results from a new sub- analysis of the JUPITER study show that patients with low to normal cholesterol levels and elevated high sensitivity C-reactive protein (hsCRP) who attained a dual treatment target of LDL-C <70mg/dL and hsCRP <2mg/L with CRESTOR(R) (rosuvastatin calcium) 20mg achieved a greater reduction in cardiovascular events compared to placebo than those who did not (65% vs 36%; p=0.033). These new data were presented at the 58th Annual American College of Cardiology Scientific Sessions (ACC) in Orlando, Florida, and published simultaneously in The Lancet.

This analysis was conducted in approximately 15,500 patients, or 87% of the entire JUPITER cohort, representing patients who had LDL-C and hsCRP values assessed at baseline and one year.

Additional results from this analysis showed:

-- Patients who achieved an LDL-C <70 mg/dL experienced a 55% reduction in cardiovascular events compared to placebo

-- Patients who achieved a dual treatment target of LDL-C<70 mg/dL and hsCRP <1 mg/L achieved a 79% reduction in CV events compared to placebo

"JUPITER demonstrated the effect of rosuvastatin on cardiovascular morbidity and mortality," said Alex Gold, MD, Executive Director, Clinical Development, AstraZeneca US. "In this analysis, patients treated with rosuvastatin who achieved low levels of LDL-C and hsCRP had a greater reduction in cardiovascular events."

Rosuvastatin 20mg was well tolerated in nearly 9,000 patients during the course of the JUPITER study.

ABOUT JUPITER:

Results from the primary analysis of JUPITER (Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin), originally presented in November 2008 at the American Heart Association's Annual Scientific Sessions, and published by the
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. CRESTOR(R) Reduced Risk of Blood Clots in the Veins
6. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
7. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
8. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
9. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
10. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
11. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, ... therapeutic devices to address infectious disease, cancer and ... Advanced Research Projects Agency (DARPA) has informed the ... to proceed with year four of a five-year ... on September 30, 2011 under DARPA,s Dialysis-Like Therapeutics ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
... Calif., Oct. 25 Applied Seals North ... products used in ultraclean manufacturing of nanoelectronics and ... capabilities at its Silicon Valley headquarters with the ... Chen joins the company,s product engineering team to ...
... EAST BRUNSWICK, N.J., Oct. 25 Savient Pharmaceuticals, Inc. (Nasdaq: ... process to identify, following the approval of KRYSTEXXA™ by the ... the sale of the Company did not result in a ... directors will continue to evaluate strategic alternatives available to the ...
Cached Medicine Technology:Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 3
(Date:9/22/2014)... Career Step, an online provider of ... and exhibiting at the 86th Annual Convention and ... (AHIMA) in San Diego, California. The conference is ... Career Step will be exhibiting in booth 711 ... products, including CLiMâ„¢, its coder lifecycle management solution, ...
(Date:9/22/2014)... Airbus Helicopters Inc. (AHI) honored leaders of the air ... safety and quality of service. The annual Jim Charlson ... award, both sponsored by AHI, were presented to recipients ... , PHI Air Medical President David Motzkin ... given annually to an individual who has made significant ...
(Date:9/22/2014)... The Philadelphia 100, which honors the fastest ... year, is considered a hallmark of entrepreneurship in the ... proud to announce it has earned a spot among ... the Philadelphia 100 awards banquet on October ... of the year, as well as a separate winners-only ...
(Date:9/22/2014)... ANN ARBOR, Mich. A surprising new study pulls ... issues in health care: differences in payment and income ... those who don,t. , Contrary to perception, the ... "rigged" to favor surgeons and other procedure-performing doctors. , ... a simple difference in pay per minute explains why ...
(Date:9/22/2014)... Alan Mozes HealthDay ... Pediatricians, take note: Many American parents are aware of online ... choose a pediatrician for their children, according to a new ... more than 1,600 parents -- further suggest that negative online ... that doctor has been recommended by a neighbor. Conversely, ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3
... International Retail Expansion, With Near Term Focus on Top ... ExtensionIRVINE, Calif., Jan. 21 University Medical ... and efficacy-based skin and beauty care products sold at ... U.S., announced today that it has appointed Tom Roche ...
... following statement can be attributed to Michael J. ... consistently said two things: We are not inherently ... we have urged public policy makers to think ... without conditions, because without conditions the merger would ...
... 21 Omnicell, Inc. (Nasdaq: OMCL ), a leading provider ... 29 to discuss the Company,s fourth quarter 2008 financial results. , ... webcast, ... Who: Randall Lipps, chairman, president and chief executive officer, ...
... (Nasdaq: IDXX ), has scheduled the release of ... January 30, at approximately 7:00 a.m. (eastern). The Company will ... on that day. Individuals can access a live Webcast of ... site, www.idexx.com . An archived edition of the call ...
... Carolina researchers say it could detect virus that can ... -- A new urine test that can detect a ... to better diagnosis and treatment of patients with polyomavirus ... patients. , Polyomaviruses are harmless to healthy adults ...
... -- Schizophrenia may blur the boundary between internal and ... involved in self-reflection, and thus causing an exaggerated focus ... study has found. , The traditional view of ... that characterize the disease are caused by disconnections among ...
Cached Medicine News:Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 3Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 3
... surgical knives single-use blades deliver a ... the low friction coefficient achieved with ... diamond surgical knives feature top-of-the-line, reusable ... capabilities based on the diamond expertise ...
... is a bioresorbable implant that is used ... This proprietary, user-friendly design, shaped like ... fit into burr holes and requires no ... has superior mechanical strength and the scaffold ...
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... heparinized glass capillary devices wrapped ... tubes are used for the ... for the measurement of pH, ... lithium) and can hold up ...
Medicine Products: